Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 446-620-9 | CAS number: 120983-72-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Sept 2002 - Jan 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 473
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- -
- EC Number:
- 446-620-9
- EC Name:
- -
- Cas Number:
- 120983-72-4
- Molecular formula:
- Hill formula: C5H6Cl2O CAS formula: C5H6Cl20
- IUPAC Name:
- 2-chloro-1-(1-chlorocyclopropyl)ethan-1-one
- Test material form:
- liquid
- Details on test material:
- purity: 92.3 %
Constituent 1
- Specific details on test material used for the study:
- purity 93.2%, Identity and stability tested analytically
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- The karyotype of the V79 cells (modal number of chromosomes: 22) was confirmed on August 9, 2002.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9 mix
- Test concentrations with justification for top dose:
- Concentration range in the main test (with metabolic activation): 1 - 8 µg/ml
Concentration range in the main test (without metabolic activation): 0.5 - 4 µg/ml
- Details on test system and experimental conditions:
- Exposure period (with metabolic activation): 4 hours
Exposure period (without metabolic activation): 4 hours
Expression time:
4 h
Selection time:
Experiment 1: 18 h (with and without metabolic activation)
Experiment 2: 30 h (with and without metabolic activation)
Fixation time:
2 h
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (>2 µg/ml)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (> 7 µg/ml)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Observations:
The substance showed clear cytotoxic effects. An indirect
cyctoxicity based mutagenic effect may be possible.
Any other information on results incl. tables
Mitotic index without S9 mix: In comparison to the solvent control, the mitotic indices in the treated cultures were relevantly reduced at 2 μg/ml and above. The cultures treated with mitomycin C showed no reduction in mitosis rate.
Mitotic index with S9 mix: In comparison to the solvent control, the treated cultures showed no relevant reduction of the mitosis rate. The positive control cyclophosphamide also reduced the mitosis rate.
Survival index without S9 mix: In comparison to the solvent control, the survival indices in the treated cultures were relevantly reduced at 2 μg/ml and above. The cultures treated with mitomycin C showed a reduction in survival rate.
Survival index with S9 mix: In comparison to the solvent control, the treated cultures showed a relevant reduction of the survival rate at 7 μg/ml and above. The positive control cyclophosphamide also reduced the survival rate.
Chromosome Aberrations
JAU 64 76-Chloromethylketone without S9 mix: Biologically relevant and statistically significant increases of numbers of metaphases with aberrations were detected after 18 or 30 hours culture time. The treatment with the positive control mitomycin C resulted in a clear and statistically significant increase of metaphases with aberrations and demonstrated the sensitivity of the test system.
JAU 64 76-Chloromethylketone with S9 mix: Biologically relevant and statistically significant increases of metaphases with aberrations were detected after total culture times of 18 or 30 hours. The positive control cyclophosphamide induced statistically significant and biologically relevant increases of metaphases with aberrations and demonstrated the sensitivity of the test system and the activity of the used S9 mix.
Applicant's summary and conclusion
- Conclusions:
- Based on the results of this test, JAU 64 76-Chloromethylketone is considered to be clastogenic for mammalian cells in vitro. Since nucleus disintegration was observed at 2 μg/ml (without S9 mix) and at 8 μg/ml (with S9 mix), an indirect cytotoxicity based effect may be possible.
- Executive summary:
The clastogenic potential of JAU 64 76-Chloromethylketone was evaluated in a chromosome aberration test in vitro. lnitially Chinese hamster V79 cells were exposed in the absence of S9 mix for 4 hours to concentrations of 0.5, 1, 2, 3 and 4 μg/ml of JAU 6476-Chloromethylketone. Cultures of all concentrations were harvested 18 hours after the beginning of the treatment. In addition, cells treated with 2, 3 and 4 μg/ml were harvested 30 hours after the beginning of the treatment. In the presence of S9 mix cells were exposed for to concentrations of 1, 3, 6, 7 and 8 μg/ml of JAU 6476 Chloromethylketone. Cultures of all concentrations were harvested 18 hours after the beginning of the treatment. In addition, cells treated with 6, 7 and 8 μg/ml were harvested 30 hours after the beginning of the treatment. Based on their cytotoxicity concentrations were selected for reading of metaphases. Without S9 mix cytotoxic effects were observed at 2 μg/ml and above. With S9 mix cytotoxic effects were observed at 7 μg/ml and above. Precipitation of JAU 6476 -Chloromethylketone in the medium was not observed. Therefore, concentrations of 0.5, 1 and 2 μg/ml JAU 6476-Chloromethylketone were chosen for reading in the absence of S9 mix. In the presence of S9 mix 1, 6 and 8 μg/ml of JAU 6476-Chloromethylketone were employed. All of these cultures harvested 18 hours after the beginning of the treatment were included. In addition, cultures treated in the absence of S9 mix with 2 μg/ml and harvested 30 hours after the beginning of the treatment were used. The same was true for cultures treated in the presence of S9 mix with 8 μg/ml. In the absence and in the presence of S9 mix cultures treated with JAU 6476- Chloromethylketone showed biologically relevant and statistically significant increased numbers of aberrant metaphases. The positive controls mitomycin C and cyclophosphamide induced clastogenic effects and demonstrated the sensitivity of the test system and the activity of the used S9 mix. Based on this test, JAU 64 76-Chloromethylketone is considered to be clastogenic for mammalian cells in vitro. Since nucleus disintegration was observed at 2 μg/ml (without S9 mix) and at 8 μg/ml (with S9 mix), an indirect cytotoxicity based effect may be possible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.